This is an article written by Misha Angrist is an assistant professor at the Duke University Institute for Genome Sciences and discusses what do we do with our genome once we get it? Actually the article talks about where we are today with the technology. The only thing I think that we all...
Only requires a blood sample, but the cost is not cheap, but neither is a heart transplant. If one were having a transplant, this could be very valuable to know up front about potential rejection issues that would arise after the fact. BD The Food and Drug Administration said the test...
Patrice Milos, Vice President and Chief Scientific Officer, Helicos Biosciences This week I had the opportunity to talk with Patrice Milos from Helicos Biosciences who has a long background in global research and spent a number of years at Pfizer as Executive Director at Pfizer Global Research and Development...
After all the recent news about the PSA test, here's a genomics answer. The MD Anderson Cancer Center, demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells. The new prostate cancer test will be performed at Clarient's Clinical...
Genetic testing gave this man an option of having a defibrillator based on family history, and wrote a book about it. After having seen his father drop dead and other genetic findings, he determined he should have the device. It has not been an easy road and he wrote a book about his experience...
Recently the FDA announced it was going to use the Medicare data base in the effort to mine and help find adverse drug side effects as well as other pertinent data relative to the approval and warning process in place at the FDA. This is more than likely related to the latest technology updates...
One CEO comes out and states how biotech will be the new focus for Glaxo, as in a related story whereby patients will require genetic testing for their AIDS drug, Ziagen. In the future I’m sure there will be more about big pharma and their biotech strategies as personalized medicine continues...
What would occur is to use the plant to make a protein to use the body’s own immune system to fight cancer. The plant were infected with the tobacco plants with a virus from the patient’s cancer cells and as little as a week later, the protein cells are extracted. It has been tested on a...
More business action with big pharma and the biotech industry, although Roche and Genentech already are invested together and have worked on conjunction on research projects. Roche acquired a majority in Genentech in 1990 and currently owns 55.9% of all outstanding shares. Roche...
Pfizer is wasting no time to get the calculations running and numbers rolling. To stay in the market, they are attempting to find out as much as they can about potential side effects and other perhaps adverse affects of their drugs. Better than they find up them front, as it will make for better...